Austin — Shattuck Labs, a spinout of cancer drug developer Heat Biologics, added a cash windfall right before the holiday weekend—a $46.6 million equity round of financing, according to a May 25 securities filing. Austin-based Shattuck has an experimental immunotherapy in preclinical development that it believes can fulfill two lofty goals that are currently among the […]
Original Article: Eying Clinical Trials, Shattuck Labs Adds $46M for Immunotherapy R&D